Cannabis Use Disorder
96
34
37
38
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
22 trials with published results (23%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.2%
4 terminated out of 96 trials
90.5%
+4.0% vs benchmark
7%
7 trials in Phase 3/4
58%
22 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (96)
Sex Differences in Neurobehavioral Response to THC
Neuroimaging of Adolescent Cannabis Use Treatment
A Study of Cannabidiol in Young Adult Cannabis Users
Cannabidiol and Cannabis Concentrate Users
Stress and Pain in People Living With HIV
Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
A Brief Intervention for Cannabis Use
Deep Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
Cannabis Reduction and Functional Outcomes
Psilocybin-assisted Treatment for Cannabis Use Disorder
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
SV2A Density Cannabis Use Disorder
Study of Oral Fluid Testing Approach
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
SV2 PET Imaging With [11C]APP311